Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
EDAP
#3096
EDAP TMS SA
4.3
7
-1.80%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.80%
Variazione Mensile
+5.56%
Variazione di 6 mesi
+173.12%
Variazione Annuale
+65.53%
Chiusura Precedente
4.4
5
Open
4.3
7
Bid
Ask
Low
4.3
7
High
4.3
7
Volume
2
Mercati
Mercato Azionario Statunitense
Salute
EDAP
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
29.17 M
33.47 M
36.91 M
37.1 M
37.39 M
144.87 M
Valuation ratios
Enterprise value
150.78 M
200.46 M
385.35 M
197.02 M
82.64 M
865.47 M
Price to earnings ratio
-86.17
299.5
-116
-9.32
-4.33
169.85
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
—
—
—
—
—
Return on equity %
—
—
—
—
—
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
—
—
—
—
—
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Notizie
EDAP riporta ricavi HIFU record e fornisce solide previsioni per il 2026
EDAP reports record HIFU revenue, issues strong 2026 guidance
RBOT Enters Strategic Software Partnership to Streamline Development
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
EDAP riceve l’approvazione FDA per il sistema robotico HIFU Focal One potenziato
EDAP receives FDA clearance for enhanced Focal One robotic HIFU system
Obiettivo di prezzo delle azioni EDAP TMS aumentato a $2,00 da $1,80 da Jefferies
EDAP TMS stock price target raised to $2.00 from $1.80 at Jefferies
Gli EPS di EDAP hanno battuto le aspettative per 0,08€, il fatturato supera le previsioni
EDAP earnings beat by €0.08, revenue topped estimates